Privia Health Group (PRVA)
(Delayed Data from NSDQ)
$20.58 USD
+1.07 (5.48%)
Updated Aug 8, 2025 03:59 PM ET
After-Market: $20.58 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value A Growth A Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
PRVA 20.58 +1.07(5.48%)
Will PRVA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PRVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRVA
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics
Privia Health (PRVA) Misses Q2 Earnings Estimates
PRVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say
Privia Health (PRVA) Misses Q1 Earnings Estimates
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Other News for PRVA
Decoding Privia Health Group Inc (PRVA): A Strategic SWOT Insight
Q2 2025 Privia Health Group Inc Earnings Call Transcript
Privia Health raises 2025 outlook above prior range as implemented providers climb 13.8% and value-based lives grow 15.2%
Privia Health Group, Inc. (PRVA) Q2 2025 Earnings Call Transcript
Privia Health Group Non-GAAP EPS of $0.24, revenue of $521.2M